Gordon A Ferns, Sheida Shabanian, Milad Shahini Shams Abadi, Ahmadshah Farhat, Mohammad-Hassan Arjmand
{"title":"Prognostic and Clinicopathologic Significance of Discoidin Domain Receptors in Different Human Malignancies: A Meta-Analysis.","authors":"Gordon A Ferns, Sheida Shabanian, Milad Shahini Shams Abadi, Ahmadshah Farhat, Mohammad-Hassan Arjmand","doi":"10.1159/000517503","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Discoidin domain receptors (DDRs) belong to the receptor tyrosine kinases family and are activated by different types of collagens, which play roles in various physiological processes. An abnormal expression of DDRs is reported in different types of cancers. Despite many reports about the association and roles of high DDR expression levels in cancers, the prognostic values of DDRs are still unclear. This meta-analysis was performed to evaluate the prognostic effect of DDRs in different tissue cancers.</p><p><strong>Method: </strong>A literature search was performed in several related databases to find eligible English articles. Based on our research, 20 appropriate studies with 2,602 patients were selected till October 5, 2020. The pooled hazard ratio (HR) with a corresponding 95% confidence interval (CI) was computed to evaluate the strength of correlation between DDRs and survival of cancer patients.</p><p><strong>Result: </strong>Pooling results showed that a high DDR expression was significantly associated with poorer overall survival (OS) (HR = 1.304, 95% CI 1.007-1.69, <i>p</i> = 0.04). Subgroup analysis based on cancer type revealed a significant link between a high DDR expression level and poor OS both in gastrointestinal (pooled HR = 1.78, 95% CI 1.214-2.624, <i>p</i> = 0.003) and urological cancers (pooled HR = 1.42, 95% CI 1.062-1.82, <i>p</i> = 0.018).</p><p><strong>Conclusion: </strong>Our meta-analysis results suggest that high DDRs expression has the potential to be used as a biomarker of poor prognosis in cancers.</p>","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"8 4","pages":"177-186"},"PeriodicalIF":0.8000,"publicationDate":"2021-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000517503","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastrointestinal Tumors","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000517503","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/10/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Discoidin domain receptors (DDRs) belong to the receptor tyrosine kinases family and are activated by different types of collagens, which play roles in various physiological processes. An abnormal expression of DDRs is reported in different types of cancers. Despite many reports about the association and roles of high DDR expression levels in cancers, the prognostic values of DDRs are still unclear. This meta-analysis was performed to evaluate the prognostic effect of DDRs in different tissue cancers.
Method: A literature search was performed in several related databases to find eligible English articles. Based on our research, 20 appropriate studies with 2,602 patients were selected till October 5, 2020. The pooled hazard ratio (HR) with a corresponding 95% confidence interval (CI) was computed to evaluate the strength of correlation between DDRs and survival of cancer patients.
Result: Pooling results showed that a high DDR expression was significantly associated with poorer overall survival (OS) (HR = 1.304, 95% CI 1.007-1.69, p = 0.04). Subgroup analysis based on cancer type revealed a significant link between a high DDR expression level and poor OS both in gastrointestinal (pooled HR = 1.78, 95% CI 1.214-2.624, p = 0.003) and urological cancers (pooled HR = 1.42, 95% CI 1.062-1.82, p = 0.018).
Conclusion: Our meta-analysis results suggest that high DDRs expression has the potential to be used as a biomarker of poor prognosis in cancers.
背景:盘状蛋白结构域受体(disidin domain receptor, DDRs)属于受体酪氨酸激酶家族,可被不同类型的胶原激活,在多种生理过程中发挥作用。DDRs的异常表达在不同类型的癌症中都有报道。尽管有许多关于DDR高表达水平在癌症中的关联和作用的报道,但DDR的预后价值仍不清楚。本荟萃分析旨在评估ddr在不同组织癌中的预后作用。方法:在相关数据库中检索符合要求的英文文章。根据我们的研究,到2020年10月5日,我们选择了20项合适的研究,2602例患者。计算合并风险比(HR)和相应的95%置信区间(CI),以评估ddr与癌症患者生存之间的相关性强度。结果:合并结果显示,DDR高表达与较差的总生存期(OS)显著相关(HR = 1.304, 95% CI 1.007-1.69, p = 0.04)。基于癌症类型的亚组分析显示,高DDR表达水平与胃肠道(合并HR = 1.78, 95% CI 1.214-2.624, p = 0.003)和泌尿系统癌症(合并HR = 1.42, 95% CI 1.062-1.82, p = 0.018)的不良OS之间存在显著联系。结论:我们的荟萃分析结果表明,高DDRs表达有可能被用作癌症预后不良的生物标志物。